PREDICTION OF RESPONSE TO INTERFERON THERAPY BY SERUM LEVELS OF TYPE-IV COLLAGEN AND PROLYL HYDROXYLASE IN CHRONIC HEPATITIS-C

被引:0
作者
MIYABAYASHI, C
HIGUCHI, K
AIBA, N
SHIMIZU, Y
NAMBU, S
TAKAHARA, T
WATANABE, A
机构
[1] The Third Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, 930-01
来源
INTERNATIONAL HEPATOLOGY COMMUNICATIONS | 1994年 / 2卷 / 03期
关键词
TYPE-IV COLLAGEN; PROLYL HYDROXYLASE; INTERFERON; CHRONIC HEPATITIS-C;
D O I
10.1016/0928-4346(94)90049-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We evaluated histological activity index (HAI) score and serum markers of liver fibrosis, type IV collagen (IV-C) and prolyl hydroxylase (PH), to analyze whether they are predictors of response to interferon (IFN) treatment for chronic hepatitis C. Efficacy of IFN therapy was evaluated in 16 patients. Mean serum levels of IV-C and PH before treatment in five responders were lower than those in 11 non-responders (not significant). Among seven patients whose IV-C values were less than 200 ng/ml and PH less than 80 ng/ml, five patients (71.4%) were responders. The response rate of these seven patients was significantly (P < 0.005) higher than that (0%) in the other nine patients. When patients were histologically divided by the total HAI scores, the response rate to IFN in patients with low HAI score (10 or less) was 71.4% (five of seven patients), while that in patients with high HAI score (more than 10) was 0%. The result that the response rate to IFN in patients with low serum IV-C and PH levels equaled that in patients with low HAI score suggests that the efficacy of IFN treatment may be predictable by measuring serum levels of IV-C and PH in patients with chronic hepatitis C.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 50 条
  • [21] RAISING THE DOSE OF INTERFERON DOES NOT IMPROVE THE RESPONSE IN CHRONIC HEPATITIS-C
    FONG, TL
    MORGAN, TR
    PHAN, CG
    HOEFS, JC
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 20 (01) : 42 - 44
  • [22] Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients
    Tas, Faruk
    Bilgin, Elif
    Karabulut, Senem
    Duranyildiz, Derya
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 195 - 200
  • [23] Accurate prediction of response to interferon therapy by repeated measurement of hepatitis C virus core protein in patients with chronic hepatitis C
    Nishiguchi, S
    Enomoto, M
    Tanaka, M
    Fukuda, K
    Tamori, A
    Habu, D
    Takeda, T
    Shiomi, S
    Tanaka, T
    Yano, Y
    Otani, S
    INTERVIROLOGY, 2002, 45 (02) : 105 - 110
  • [24] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS AND EFFECTS OF INTERFERON-ALPHA FOR PATIENTS WITH CHRONIC HEPATITIS-C VIRUS
    HAYASHI, J
    KISHIHARA, Y
    YAMAJI, K
    YOSHIMURA, E
    OHMIYA, M
    TANI, Y
    IKEMATSU, H
    KASHIWAGI, S
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (08) : 1837 - 1841
  • [25] USEFULNESS OF SIMPLE ASSAYS FOR SERUM CONCENTRATION OF HEPATITIS-C VIRUS-RNA AND HCV GENOTYPE IN PREDICTING THE RESPONSE OF PATIENTS WITH CHRONIC HEPATITIS-C TO INTERFERON ALPHA-2A THERAPY
    SUZUKI, T
    TANAKA, E
    MATSUMOTO, A
    URUSHIHARA, A
    SODEYAMA, T
    JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (02) : 162 - 168
  • [26] Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon
    Arai, M
    Niioka, M
    Maruyama, K
    Wada, N
    Fujimoto, N
    Nomiyama, T
    Tanaka, S
    Okazaki, I
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (05) : 995 - 1000
  • [27] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA
    MORISHIMA, I
    KUMADA, T
    NAKANO, S
    TAKEDA, I
    SUGIYAMA, K
    OSADA, T
    KIRIYAMA, S
    OHKI, H
    SUGA, T
    ITO, O
    EBATA, M
    TAKAHASHI, M
    TOYODA, H
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (08) : 807 - 811
  • [28] Serum amino-terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following α-interferon therapy
    Shimizu, I
    Omoya, T
    Takaoka, T
    Wada, S
    Wada, H
    Taoka, M
    Hayashi, H
    Hayashi, S
    Honda, H
    Sano, N
    Ito, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (02) : 196 - 201
  • [29] The Effect of Antiviral Therapy on Serum Cholesterol Levels in Chronic Hepatitis C
    Jang, Eun Sun
    Won, Ji-Eon
    Jung, Jae Ii
    Lee, Sang-Hyub
    Kim, Jin Wook
    Jeong, Sook-Hyang
    GUT AND LIVER, 2011, 5 (03) : 356 - 362
  • [30] SERUM LEVELS OF LAMININ, TYPE-IV COLLAGEN AND TYPE-III PROCOLLAGEN PEPTIDE AS MARKERS FOR DETECTION OF METASTASIS
    YUDOH, K
    MATSUI, H
    KANAMORI, M
    OHMORI, K
    TSUJI, H
    TATEZAKI, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (12): : 1263 - 1269